Download Citation
Article Source:
Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]
Brooks BR,
Heiman-Patterson T,
Wiedau-Pazos M,
Liu S,
Zhang J,
et al.
(2022)
Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686].
PLOS ONE 17(6): e0258614.
https://doi.org/10.1371/journal.pone.0258614